Replies to post #385 on Relmada Therapeutics Inc. (RLMD)

[Biobonic]

Nice move these past weeks.

RLMD has only one drug in the pipeline. (But what a drug!)

Stellar results from the Phase 2 trial. (That does mean the time to plan and execute a Phase 3 is measured in years.)

Shares from financing went off lock up last month. (Millions)

RLMD announces a mixed shelf offering for up to $200 million.

All these events should combine for a price swoon.

BUT NO! Price has stabilized and has even climbed.

Wonder if moderator caught the last train for the coast, the West Coast?

My three g-kids all under 4 years old have some in their accts.
(Working to give them a nice financial start to their adult life.)